Effect of RBT-1 on Preconditioning Response Biomarkers in Subjects Undergoing CABG and/or Cardiac Valve Surgery (START)
Diseases of the Cardiovascular System
What is the purpose of this trial?
The purpose of this study is to evaluate the effect of RBT-1 (stannous protoporphyrin [SnPP]/iron sucrose [FeS]) on preconditioning response biomarkers in subjects who are at risk for AKI following cardiac surgery.
- Ages18 years and older
- Trial withRenibus Therapeutics, Inc.
- Start Date10/06/2021
- End Date06/30/2022
- Last Updated02/10/2022
- Study HIC#2000030910